TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons by Schwenk, B. et al.
Article
TDP-43 loss of function inhibits endosomal
trafficking and alters trophic signaling in neurons
Benjamin M Schwenk1,2, Hannelore Hartmann1, Alperen Serdaroglu1,3, Martin H Schludi1,2, Daniel
Hornburg4, Felix Meissner4, Denise Orozco1, Alessio Colombo1, Sabina Tahirovic1, Meike Michaelsen1,
Franziska Schreiber1, Simone Haupt5, Michael Peitz6,7, Oliver Brüstle6, Clemens Küpper2,8, Thomas
Klopstock1,2,8, Markus Otto9, Albert C Ludolph9, Thomas Arzberger1,10,11, Peer-Hendrik Kuhn1,3,12 &
Dieter Edbauer1,2,13,*
Abstract
Nuclear clearance of TDP-43 into cytoplasmic aggregates is a key
driver of neurodegeneration in amyotrophic lateral sclerosis (ALS)
and frontotemporal lobar degeneration (FTLD), but the mecha-
nisms are unclear. Here, we show that TDP-43 knockdown specifi-
cally reduces the number and motility of RAB11-positive recycling
endosomes in dendrites, while TDP-43 overexpression has the
opposite effect. This is associated with delayed transferrin recy-
cling in TDP-43-knockdown neurons and decreased b2-transferrin
levels in patient CSF. Whole proteome quantification identified the
upregulation of the ESCRT component VPS4B upon TDP-43 knock-
down in neurons. Luciferase reporter assays and chromatin
immunoprecipitation suggest that TDP-43 represses VPS4B tran-
scription. Preventing VPS4B upregulation or expression of its func-
tional antagonist ALIX restores trafficking of recycling endosomes.
Proteomic analysis revealed the broad reduction in surface expres-
sion of key receptors upon TDP-43 knockdown, including ErbB4,
the neuregulin 1 receptor. TDP-43 knockdown delays the surface
delivery of ErbB4. ErbB4 overexpression, but not neuregulin 1 stim-
ulation, prevents dendrite loss upon TDP-43 knockdown. Thus,
impaired recycling of ErbB4 and other receptors to the cell surface
may contribute to TDP-43-induced neurodegeneration by blocking
trophic signaling.
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Introduction
TDP-43 is a DNA/RNA-binding protein that represses transcription
and regulates RNA metabolism predominantly in the nucleus. Cyto-
plasmic TDP-43 inclusions are pathological hallmarks of most ALS
and FTLD cases, and their regional distribution correlates remark-
ably well with neurodegeneration (Geser et al, 2009b; Ling et al,
2013). Degeneration of the frontal and temporal lobe in FTLD causes
behavioral changes as well as speech and language impairment.
Degeneration of upper and lower motoneurons in ALS leads to
progressive paralysis (Ferrari et al, 2011). Both diseases often over-
lap clinically and share a strong genetic component with several
genes linked to both ALS and FTLD (Ling et al, 2013). Pathogenic
mutations in TDP-43 are found in 1–3% of familial ALS cases and
seem to mainly promote aggregation without the obvious deleteri-
ous effects on the function of the soluble TDP-43 (Kabashi et al,
2008; Sreedharan et al, 2008; Johnson et al, 2009). Intriguingly,
TDP-43 inclusions are found in about 90% of ALS and 45% of FTLD
cases (Geser et al, 2009a; Mackenzie et al, 2010), including most
sporadic cases without known causal mutation. Hippocampal
TDP-43 inclusions are also common in Alzheimer cases, where they
are associated with cognitive decline (Davidson et al, 2011).
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Most cells with TDP-43 aggregates show nearly complete clear-
ance of nuclear TDP-43, suggesting a combination of loss of nuclear
function and gain of toxic function. Although the physiological role
of TDP-43 is incompletely understood, many putative RNA targets
have been identified, which are essential for neuronal function and
survival (Buratti et al, 2013). Despite the mostly nuclear localization
of TDP-43, a smaller cytoplasmic TDP-43 fraction has been impli-
cated in axonal trafficking of mRNA transport granules (Alami et al,
2014). Overexpression of wild-type or mutant TDP-43 causes neuron
loss, and complete TDP-43 knockout is lethal in mice (Gendron &
Petrucelli, 2011). Selective neurodegeneration in conditional knock-
out mice suggests that cell-autonomous effects govern the toxicity
(Wu et al, 2012). As homozygous knockout mice die in an early
embryonic stage, TDP-43 is thought to have a crucial role in funda-
mental cellular pathways (Gendron & Petrucelli, 2011). Despite a
large number of RNAs potentially binding to TDP-43, the major
cause of neurotoxicity upon knockout is still unclear (Polymenidou
et al, 2011; Tollervey et al, 2011).
Several proteins genetically linked to TDP-43 pathology play
important roles in the endolysosomal pathway, which consists of
different vesicle pools distinguishable by specific RAB-GTPases
that regulate vesicle transport. The key compartments are RAB5-
positive early endosomes, RAB11-positive recycling endosomes,
and RAB7-positive late endosomes/lysosomes (Schwartz et al,
2007). In addition, RAB4-positive endosomes allow faster recycling
to the plasma membrane by skipping the endosomal recycling
compartment critical for RAB11-dependent recycling (Sonnichsen
et al, 2000; Maxfield & McGraw, 2004). This network governs the
sorting of internalized cell surface proteins either for lysosomal
degradation or for recycling to the plasma membrane and thus
controls cellular signaling. CHMP2B is part of the endosomal sort-
ing complexes required for transport (ESCRT) that mediates
membrane remodeling, and rare FTLD-causing mutations in
CHMP2B disrupt endocytic trafficking and fusion with lysosomes
(Skibinski et al, 2005; Urwin et al, 2010). The ESCRT complex
consists of four cytosolic protein complexes (ESCRT-0, -I, -II, and
-III) that regulate together with ESCRT accessory factors, for exam-
ple, VPS4 and ALIX, membranes bending and budding. This
machinery is crucial for cellular processes such as vesicle sorting,
MVB biogenesis, virus budding, and cellular abscission (Tu et al,
2011). Moreover, the FTLD-TDP risk factor TMEM106B controls
trafficking of RAB7-positive lysosomes in dendrites (Schwenk et al,
2014; Stagi et al, 2014). While GRN haploinsufficiency is a
common cause of FTLD with TDP-43 pathology, rare patients with
homozygous loss of GRN suffer from the lysosomal storage disease
neuronal ceroid lipofuscinosis (Smith et al, 2012). Vice versa,
patients with neuronal ceroid lipofuscinosis show signs of TDP-43
pathology (Gotzl et al, 2014). Pathogenic mutations in TBK1 and
OPTN suggest that altered autophagy may trigger ALS and FTLD
with TDP-43 pathology (Cirulli et al, 2015; Freischmidt et al,
2015). These chronic defects in protein degradation eventually lead
to the aggregation of TDP-43. Here, we asked how loss of TDP-43
harms neuron function using live imaging of endosomes in
primary neurons transfected with different fluorescently labeled
vesicular markers and identified new TDP-43 targets by whole
proteome quantification. We validated key findings in patient-
derived material. This uncovered an unexpected link of TDP-43
with another ALS-associated gene, ErbB4.
Results
Loss of TDP-43 in primary neurons reduces the number and
motility of recycling endosomes
To analyze the role of TDP-43 on trafficking in the endolysosomal
compartment in primary neurons, we generated specific shRNA
constructs. Knockdown efficiency was confirmed on mRNA and
protein levels in rat primary hippocampal neurons transduced with
a lentivirus expressing either the TDP-43 shRNA (shTDP) or a
control shRNA (shCtrl, targeting firefly luciferase) (Appendix
Fig S1A–C). Moreover, transfecting hippocampal neurons with the
TDP-43 shRNA reduced TDP-43 levels detected by immunofluores-
cence within three days (Appendix Fig S1D).
Next, we cotransfected hippocampal neurons at six days
in vitro with shTDP or shCtrl together with GFP-tagged vesicle
markers (RAB4, RAB5, RAB7, RAB11) to analyze how the loss of
TDP-43 affects endolysosomal trafficking (Figs 1, EV1, and EV2).
After three days of knockdown (DIV6+3), we analyzed organelle
transport in dendrites by live cell imaging of the transfected
neurons and subsequently transformed the images into kymo-
graphs (path-time diagrams of organelle transport) to visualize the
movement pattern. We quantified the total number and the
number of moving and stationary GFP-labeled vesicles from these
kymographs. Among the tested vesicle pools, TDP-43 knockdown
had the strongest effect on RAB11-positive recycling endosomes.
The dendritic motility of GFP-RAB11-labeled endosomes was
strongly reduced in TDP-43-knockdown neurons compared to
controls (Fig 1A–C). While the number of stationary recycling
endosomes was unchanged, the number of mobile recycling endo-
somes was reduced to half upon TDP-43 knockdown (Fig 1B)
resulting in an overall loss of RAB11-positive recycling endosomes
(Fig 1C). We found no colocalization of TDP-43 and GFP-RAB11
in primary neurons (Appendix Fig S1E), suggesting that TDP-43
regulates a key protein in the recycling pathway. The effects of
TDP-43 on recycling endosome motility were fully confirmed
using a second shRNA (Appendix Fig S2A–D). In contrast, knock-
down of TMEM106B, linked to TDP-43 pathology and lysosomal
trafficking (Schwenk et al, 2014; Stagi et al, 2014), did not affect
GFP-RAB11-labeled recycling endosomes (Appendix Fig S2E–H).
Thus, TDP-43, but not TMEM106B, is required to maintain the
proper number and motility of RAB11-positive recycling endo-
somes in dendrites.
To test whether this phenotype is conserved in humans and thus
may be relevant for FTLD/ALS, we additionally analyzed trafficking
of recycling endosomes upon TDP-43 knockdown in human
neurons. We transduced iPSC-derived human neurons with a lenti-
virus expressing a shRNA targeting human TDP-43 or a control
shRNA (Fig 1D). Similar to rat neurons, GFP-RAB11-labeled recy-
cling endosomes were less abundant and less motile (Fig 1E–G).
Hence, the role of TDP-43 in promoting the motility of recycling
endosomes is conserved between rats and humans.
Trafficking of other organelles remains intact in
TDP-43-knockdown neurons
To rule out an overall transport defect upon TDP-43 knockdown, we
analyzed the trafficking of mitochondria labeled by cotransfection
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Figure 1. TDP-43 knockdown in primary rat and iPSC-derived human neurons inhibits trafficking of recycling endosomes in dendrites.
A Primary hippocampal neurons (DIV6+3) were transfected with shRNA targeting TDP-43 (shTDP) or control (shCtrl) together with GFP-RAB11 to visualize trafficking
of recycling endosomes (RE). At least four dendrite segments per neuron were live-imaged at 5 Hz for 1 min to analyze recycling endosome transport.
Representative dendrite segments and kymographs of GFP-RAB11 vesicle movement.
B, C Quantitative analysis of vesicle motility (B) and the total number (C) from kymographs in (A).
D iPSC-derived human neurons were transduced 7 days after thawing for 3 days with shRNA targeting human TDP-43 (shTDP) or control (shCtrl). TDP-43 levels were
analyzed by quantitative RT-PCR. Expression was normalized to the housekeeping genes YWHAZ and PGK1.
E iPSC-derived human neurons (DIV7+3) were transduced with shTDP or shCtrl and GFP-RAB11 and at least three dendrite segments per neuron analyzed as in (A).
Representative dendrite segments and kymographs of GFP-RAB11 vesicle movement.
F, G Quantitative analysis of vesicle motility (F) and number (G) from kymographs in (E).
Data information: Mean  s.e.m., n = 3, unpaired two-tailed t-test: *P < 0.05, **P < 0.01, ***P < 0.001.
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with mito-GFP in rat primary neurons. Mitochondria number and
motility were undistinguishable in the dendrites of neurons trans-
fected with TDP-43 or control shRNA (Fig EV1A–C), suggesting that
the loss of TDP-43 has no general effect on microtubule-mediated
transport.
Trafficking of the other endosomal populations was also not
affected by TDP-43 knockdown as analyzed by live cell imaging
of GFP-RAB5-labeled (early endosomes) and GFP-RAB4-labeled
(endosomes directly recycling to the plasma membrane) vesicles
(Fig EV1D–I). However, TDP-43 knockdown slightly promoted
the motility of GFP-RAB7-labeled lysosomes (Fig EV2A and B).
In contrast to the retrograde-specific increase in lysosomal motil-
ity upon TMEM106B knockdown (Schwenk et al, 2014), TDP-43
knockdown increased both anterograde and retrograde lysosomal
trafficking equally (Fig EV2C). The overall number of GFP-RAB7-
labeled lysosomes remained unchanged upon TDP-43 knockdown
(Fig EV2D).
Thus, TDP-43 loss specifically inhibits the motility of RAB11-
positive recycling endosomes in the dendrites potentially in favor of
lysosomal motility without impairing the transport of RAB5-positive
early endosomes, RAB4-positive fast recycling endosomes or
mitochondria.
TDP-43 knockdown inhibits transferrin recycling
To elucidate the functional consequences of impaired trafficking of
recycling endosomes, we analyzed the constitutive uptake and recy-
cling of the prototypical cargo transferrin through the endocytic
pathway. After receptor binding, the receptor–ligand complex is
endocytosed via clathrin-coated vesicles and transported to the
early/sorting endosome. Unlike many other ligands, transferrin does
not dissociate from its receptor to terminate signaling, but the whole
complex is transferred back to the plasma membrane mainly via the
ERC and RAB11-positive recycling endosomes (Sonnichsen et al,
2000). We quantified transferrin recycling by measuring the amount
of exogenously added fluorescently labeled transferrin in the
neurons directly after endocytosis and 20 or 60 min afterward.
Control shRNA-transduced rat neurons released 40% of the endocy-
tosed transferrin within 20 min and 60% within 60 min (Fig 2A and
B). In contrast, TDP-43-knockdown neurons initially took up the
same amount of labeled transferrin, but released about 30% less
after 20 and 60 min, indicating that recycling to the plasma
membrane is delayed.
To corroborate this finding in patient material, we quantified the
transferrin level in the CSF of 55 sporadic ALS patients and 65
controls. To exclude the possible confounds of altered systemic iron
metabolism (Nadjar et al, 2012) as much as possible, we focused
our analysis on the CSF-specific b2-transferrin. Consistent with
normal endocytosis but reduced recycling seen in our neuronal
model, the ALS patients had lower b2-transferrin levels in CSF than
healthy age-matched controls (Fig 2C). A smaller reduction was
seen in patients with FTD-ALS (12 patients) and behavioral variant
FTD (16 patients), which likely suffer from TDP-43 pathology,
although this did not reach statistical significance due to the smaller
cohort size.
To confirm that the reduced transport and recycling contrib-
uted to the elevated intracellular transferrin levels in the neurons
and decreased levels in the extracellular CSF, we analyzed the
motility of transferrin-containing vesicles by live cell imaging. We
again added Alexa-labeled transferrin to the neurons and imaged
20 min after endocytosis, when most of endocytosed fluorescent
transferrin is expected to have reached the endosomal recycling
compartment (Sonnichsen et al, 2000). Importantly, labeled trans-
ferrin was significantly less mobile in shTDP-transfected neurons
than in controls (Fig 2D–F), consistent with the results using
GFP-RAB11 transfection (compare Fig 1).
Thus, TDP-43 loss of function impairs dendritic trafficking of
recycling endosomes. Evidence for impaired recycling activity is
found in rat and human neurons and CSF from ALS patients.
Overexpression of nuclear, but not cytoplasmic, TDP-43 enhances
recycling endosome transport
Next, we asked whether overexpression of wild-type TDP-43 or a
mutant lacking the nuclear localization signal (DNLS) would
promote recycling endosome motility (Fig 3A). Neurons trans-
fected with wild-type TDP-43 showed a higher number of GFP-
RAB11-positive recycling endosomes compared to vector-trans-
fected cells, which was exclusively due to an increase in the
number of mobile GFP-RAB11-positive vesicles (Fig 3B–D). In
contrast, the predominantly cytoplasmic DNLS mutant did not
affect the number and motility of recycling endosomes. The oppo-
site effects of TDP-43 knockdown and overexpression on recycling
endosome motility and abundance further support the specificity
of these findings (compare Figs 1 and 3) and suggest that they are
mediated by nuclear TDP-43 rather than the smaller cytoplasmic
fraction.
To further address whether the loss of nuclear TDP-43 mediates
the effects of TDP-43 knockdown, we performed rescue experiments
using TDP-43 wild type and DNLS. Remarkably, coexpression of
wild-type, but not mutant, TDP-43 together with TDP-43 shRNA
partially restored the number and motility of GFP-RAB11-labeled
recycling endosomes (Fig EV3). In summary, these data indicate
that nuclear TDP-43 promotes recycling endosome motility by
controlling the expression or splicing of a key regulatory factor in
this pathway.
TDP-43 represses transcription of the ESCRT-III accessory
protein VPS4B
To elucidate how TDP-43 might regulate recycling endosome
trafficking, we performed a quantitative whole proteome analysis
in cortical neurons upon lentiviral TDP-43 knockdown or control
(DIV2+7) using a label-free LC-MS/MS pipeline (Hornburg et al,
2014) (Fig 4A). We observed an upregulation of proteins
involved in lipid metabolism and a strong downregulation of
proteins annotated for neuron projection, synapse, and various
transport processes upon TDP-43 knockdown (Fig 4B and
Table EV1). Comparing 5,077 quantified proteins, 63 were
changed at least threefold (log2 cutoff 1.58; Table EV1).
However, the overall changes in protein expression were modest
despite the large number of putative TDP-43 target genes.
Among the affected proteins, VPS4B (vacuolar protein sorting 4
homolog B) was one of the strongest upregulated (3.8-fold) upon
TDP-43 knockdown. VPS4B directly binds to the ALS/FTLD gene
CHMP2B to disassemble the ESCRT complex and has been
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implicated in endosomal sorting and transport (Stuchell-Brereton
et al, 2007; Du et al, 2013). In independent validations experi-
ments, both VPS4B mRNA and protein levels were about twofold
increased upon lentiviral knockdown of TDP-43 compared to
controls (Fig 4C–E). Transfection of TDP-43 shRNA confirmed an
increased VPS4B protein expression also on a single-cell level
(Fig 4F). Moreover, lentiviral TDP-43 knockdown increased
VPS4B levels also in human neurons (Fig 4G), indicating that
TDP-43 controls recycling endosome trafficking in rat and human
neurons through a conserved mechanism.
To test whether TDP-43 affects VPS4B transcription, we
generated a reporter construct containing the 1,000-bp region
upstream of the transcriptional start site of VPS4B upstream of
luciferase (Fig 5A). We transfected HEK293 cells with either
TDP-43 knockdown or overexpression constructs or the respec-
tive controls together with the VPS4B reporter construct and
analyzed luciferase expression. While TDP-43 knockdown caused
an almost threefold activation of the VPS4B promoter, TDP-43
overexpression significant inhibited VPS4B promoter activity
(Fig 5B).
Moreover, we performed chromatin immunoprecipitation to
investigate whether TDP-43 directly binds to the VPS4B promoter.
To this end, we immunoprecipitated TDP-43 from crosslinked and
sheared chromatin preparations of rat cortical neurons. Binding of
endogenous TDP-43 to the VPS4B locus was tested using eight PCR
amplicons (~200 bp each) covering the promoter region used for the
luciferase reporter. Consistent with the known binding preference of
TDP-43, we detected binding of TDP-43 to a GT-rich region in the
VPS4B promoter (Fig 5C). Moreover, we could confirm the binding
of endogenous TDP-43 to a corresponding GT-rich region in the
human VPS4B promoter in HEK293 cells and human brain tissue
(Fig 5C). Quantification of ChIP assays confirmed a significant















































































































Figure 2. TDP-43 knockdown in primary neurons inhibits transferrin recycling.
A Primary hippocampal neurons (DIV6+4) were transduced with shRNA targeting TDP-43 or a control together with tagRFP (not depicted). Representative images of
neurons subjected to Alexa-transferrin (Alexa-Tf) for 20 min (pulse) and chased for 0, 20, or 60 min in complete media. Scale bar represents 100 lm.
B Quantification of labeled cellular Alexa-Tf normalized to cell area (using tagRFP) after chase period. At least ten images per condition were analyzed per experiment
in three independent experiments.
C ELISA measurement of b2-transferrin in CSF of control subjects (n = 65) and sporadic ALS patients (n = 55), FTD-ALS patients (n = 12), and behavioral variant FTD
patients (bvFTD, n = 16).
D Primary hippocampal neurons (DIV6+3) were transfected with shTDP or shCtrl and GFP as transfection marker. After 3 days, the neurons were subjected to Alexa-Tf
for 20 min and intracellular Alexa-Tf movement was imaged as in Fig 1 afterward.
E, F Quantitative analysis of Alexa-Tf movement (E) and vesicle number (F) from kymographs. n = 3.
Data information: Mean  s.e.m., unpaired, two-tailed t-test (E, F), Mann–Whitney U-test with Bonferroni’s post-test (B) or one-way ANOVA with Dunnet’s post-test (C):
*P < 0.05, ***P < 0.001.
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Figure 3. Expression of nuclear, but not cytoplasmic, TDP-43 enhances recycling endosome motility.
A Primary hippocampal neurons (DIV6+4) were transfected with myc-tagged TDP-43 wild type or a mutant lacking the nuclear localization signal (DNLS) or an
empty vector control. Immunostaining with the indicated antibodies and DAPI to label nuclei. Scale bar represents 50 lm.
B Primary hippocampal neurons (DIV6+3) were transfected with either TDP-43 wild type, TDP-43DNLS, or an empty vector control together with GFP-RAB11 to
visualize recycling endosomes and analyzed as in Fig 1.
C, D Quantitative analysis of recycling endosome movement (C) and vesicle number (D). Mean  s.e.m., n = 4, one-way ANOVA with Tukey’s post-test: *P < 0.05,
**P < 0.01.
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Figure 4. VPS4B is increased upon TDP-43 knockdown.
A Primary cortical neurons were transduced with shTDP or control (DIV2+7) and subjected to quantitative proteomic analysis. Volcano plot shows up- and
downregulated proteins from three biological replicates. Significant changes are colored. Compare with Table EV1.
B Selected significantly enriched annotation between TDP-43 knockdown and control in proteomic data (complete data in Table EV1)
C–E Primary hippocampal neurons (DIV6+4) were transduced with lentivirus expressing shRNA targeting TDP-43 or a control. Immunoblots with the indicated
antibodies (C). Quantification of VPS4B and TDP-43 protein level using densitometry (n = 4). Expression was normalized to the housekeeping gene b-actin (D).
VPS4B mRNA level were analyzed by quantitative RT-PCR. Expression was normalized to the housekeeping genes YWHAZ and PGK1 (E).
F Primary hippocampal neurons (DIV6+3) were transfected with either shTDP or shCtrl and iRFP670. Immunostaining with the indicated antibodies. Scale bar
represents 50 lm.
G iPSC-derived human neurons were transduced 7 days after thawing for 3 days with shRNA targeting human TDP-43 (shTDP) or control (shCtrl). VPS4B levels were
analyzed by quantitative RT-PCR. Expression was normalized to the housekeeping genes YWHAZ and PGK1 (n = 3).
Data information: Mean  s.e.m., unpaired, two-tailed t-test with permutation-based (A) or Benjamini–Hochberg (B) correction: *P < 0.05, **P < 0.01, ***P < 0.001.
Source data are available online for this figure.
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Figure 5. TDP-43 represses VPS4B expression by binding to the promoter region.
A, B Luciferase assay to analyze transcriptional regulation of VPS4B by TDP-43. (A) Reporter construct expressing Renilla luciferase (R-Luc) driven by a VPS4B promoter
fragment and firefly luciferase (FF) under the TK promoter. (B) HEK293 cells were transfected with shRNAs targeting human TDP-43, a control shRNA, TDP-43 wild
type, or empty vector control together with the luciferase reporter containing the rat VPS4B promoter. VPS4B promoter-driven Renilla luciferase activity was
normalized to TK promoter-driven firefly luciferase. Quantification from six independent experiments.
C, D ChIP assay to analyze binding of TDP-43 to VPS4B promoter region in rat cortical neurons, HEK293 cells, and human brain tissue. PCR from input, negative control,
and TDP-43 immunoprecipitates. Signal intensities from at least three independent experiments for each condition were quantified by densitometry and depicted
as percentage of input.
E–H Analysis of VPS4B in the tissues of seven patients with the neuropathological diagnosis of FTLD/ALS-TDP and five healthy controls. (E, G) Immunofluorescence with
the indicated antibodies in the superior frontal gyrus or spinal cord. Scale bar represents 50 lm. (F, H) Quantification of cellular VPS4B levels. At least 50 cells per
case were analyzed.
Data information: Mean  s.e.m., unpaired, two-tailed t-test: *P < 0.05, **P < 0.01.
Source data are available online for this figure.
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enrichment of VPS4B promoter DNA in TDP-43 immunoprecipitates
(Fig 5D).
Next, we analyzed VPS4B in the frontal cortex and spinal cord of
autopsy-confirmed FTLD/ALS-TDP cases. Immunostaining revealed
an increased VPS4B expression in patients compared to age-matched
controls in both regions (Fig 5E–H). In contrast, ALS-TDP cases
lacking TDP-43 pathology in the frontal cortex showed VPS4B
upregulation only in the spinal cord, but not in the frontal cortex
(Fig EV4A–D). Moreover, we detected a similar upregulation
of VPS4B in FTLD/ALS-TDP cases compared to controls by
immunoblotting in the superior frontal gyrus (Fig EV4E and F).
Together, these data strongly suggest that nuclear TDP-43
suppresses basal transcription of VPS4B, an important component of
the ESCRT-III complex implicated in recycling endosome trafficking.
VPS4B mediates the recycling endosome impairment upon
TDP-43 knockdown
To test whether VPS4B induction upon TDP-43 knockdown contri-
butes to the reduction in recycling endosome motility in dendrites,
we analyzed trafficking of GFP-RAB11 three days after transfection
of a VPS4B expression vector (Fig 6A). Similar to the effects of TDP-
43 knockdown, the number of moving recycling endosomes in
VPS4B-transfected cells was significantly reduced compared to
controls (Fig 6B and C).
To further corroborate our hypothesis that VPS4B induction
mediates the effects of TDP-43 knockdown on RAB11-positive
vesicle transport, we performed rescue experiments using VPS4B-
specific shRNA (Fig EV4G and H). Importantly, additional knock-
down of VPS4B in TDP-43-knockdown neurons restored the
number and motility of recycling endosomes to control levels
(Fig 6D–F). Next, we manipulated ALIX, a negative regulator of
VPS4B that promotes ESCRT assembly, to strengthen the link to
the ESCRT complex. Overexpression of ALIX enhanced RAB11-
GFP motility in TDP-43-knockdown neurons nearly to control
conditions and fully restored the vesicle number (Appendix
Fig S3A–C).
Taken together, our data show that an enhanced expression of
VPS4B is necessary and sufficient for the reduced recycling endo-
some number and motility upon TDP-43 knockdown, which is likely
due to an enhanced ESCRT-III disassembly.
TDP-43 controls surface expression of ErbB4 and several other
neuronal proteins
In neurons, recycling endosomes mediate constitutive and activity-
dependent transport of many receptors to the plasma membrane.
We speculated that impaired recycling endosome mobility upon
TDP-43 loss of function would lead to a decreased cell surface
expression of crucial receptors. We thus used proteomics to identify
differentially expressed surface protein as targets of the TDP-43/
VPS4B axis.
We therefore metabolically labeled all glycoproteins with a modi-
fied glycan and tagged their cell surface fraction with a non-
membrane-permeable biotin using click chemistry (Kuhn et al,
2012). Labeled surface proteins were pulled down with streptavidin
and identified and quantified using LC-MS/MS. Among the 43
proteins that were changed at high significance level (P < 0.001),
only two were upregulated, while the vast majority was downregu-
lated, consistent with impaired recycling to the plasma membrane
(Fig 7A and Table EV2).
We focused our analysis on ErbB4 and FGFR1, two of the most
downregulated proteins on the cell surface, because they have been
linked to motoneuron survival (Teng et al, 1999) or ALS. Patho-
genic mutations in ErbB4 in patients with familial ALS were shown
to block ErbB4 signaling in response to its ligand neuregulin 1
(NRG1; Takahashi et al, 2013). FGFR1 signaling has been linked to
motor axon guidance (Shirasaki et al, 2006).
To provide further evidence for reduced surface expression (and
activity) of the receptor tyrosine kinases ErbB4 and FGFR1, we
analyzed autophosphorylation after 10-min stimulation with the
ligands NRG1 and fibroblast growth factor-1 (FGF1) (Fig 7B–E).
ErbB4 and FGFR1 phosphorylation was significantly reduced upon
ligand treatment in TDP-43-knockdown neurons although total
ErbB4 and FGFR1 protein levels were similar. To exclude transcrip-
tional effects upon TDP-43 knockdown, we measured mRNA level
of several of the most differentially expressed proteins (Fig 7F).
While ErbB4, FGFR1, and most other tested mRNAs did not differ
significantly between TDP-43 knockdown and control, c-Met and
TMEM2 showed regulation in the same direction as the protein level
arguing for a transcriptional effect in these cases.
To further corroborate the decreased surface expression of
ErbB4 upon TDP-43 knockdown, we transfected neurons with
ErbB4 tagged with a luminal HA-tag and a thrombin cleavage
site (HA/T-ErbB4) together with the shRNA constructs and
stained surface HA/T-ErbB4 using antibody feeding in live cells
followed by staining of intracellular HA/T-ErbB4 in fixed cells.
Consistent with the proteomic data, HA/T-ErbB4 surface levels
were reduced in shTDP-transfected neurons compared to controls
(Fig 7G and H). Next, we used a thrombin cleavage assay
(Passafaro et al, 2001) to directly address trafficking of ErbB4.
After removing the HA epitope of surface-expressed HA/T-ErbB4
in living cells using thrombin, we observed a delayed recovery
of surface HA/T-ErbB4 from intracellular pools in TDP-43-knock-
down neurons compared to controls (Fig 8A and B). Importantly,
overexpression of VPS4B also led to a reduced surface expression
of HA/T-ErbB4 (Fig EV5A and B), suggesting it is the main
factor behind the effects of TDP-43 on surface localization of
trophic receptors.
Thus, the cell surface expression of FGFR1 and the ALS-
associated protein ErbB4 are reduced in TDP-43-knockdown
neurons due to the impaired trafficking of recycling endosomes.
Impaired NRG1/ErbB4 signaling causes dendrite loss in TDP-43-
knockdown neurons
Since NRG1/ErbB4 signaling promotes dendrite growth in neurons
(Krivosheya et al, 2008; Cahill et al, 2012), we quantified the
complexity of dendritic branching upon TDP-43 knockdown using
Sholl analysis, as a functional readout of ErbB4 localization and
activity. To that end, we transfected neurons (DIV6+4) with TDP-43
shRNA or control and GFP to visualize the whole cell and acquired
images of individual cells. TDP-43 knockdown strongly reduced
dendritic complexity (Fig 9A and B) similar to findings in flies (Lu
et al, 2009). Overexpression of VPS4B or dominant-negative RAB11
mimicked this phenotype (Fig 9C and D and Appendix Fig S4A and
The EMBO Journal Vol 35 | No 21 | 2016 ª 2016 The Authors
The EMBO Journal TDP-43 regulates trafficking of recycling endosomes Benjamin M Schwenk et al
2358







































































































Figure 6. VPS4B upregulation is necessary and sufficient for impaired recycling endosome trafficking upon TDP-43 knockdown.
A Primary hippocampal neurons (DIV6+3) were transfected with either VPS4B or an empty vector control together with GFP-RAB11 to visualize recycling endosomes.
Neurons were imaged as in Fig 1 to analyze recycling endosome transport.
B, C Quantitative analysis of vesicle motility (B) and the number (C) from kymographs in (A) (n = 4).
D Primary hippocampal neurons (DIV6+3) were transfected with the indicated combinations of shRNA targeting TDP-43, VPS4B, and control together with GFP-RAB11
and imaged as in Fig 1.
E, F Quantitative analysis of vesicle motility (E) and the number (F) from kymographs in (D) (n = 3).
Data information: Mean  s.e.m., unpaired, two-tailed t-test (B, C) or one-way ANOVA (Tukey’s post-test) (E, F): *P < 0.05.
ª 2016 The Authors The EMBO Journal Vol 35 | No 21 | 2016
Benjamin M Schwenk et al TDP-43 regulates trafficking of recycling endosomes The EMBO Journal
2359













































































































































































































log2 ratio shTDP/shCtrl 
Figure 7.
The EMBO Journal Vol 35 | No 21 | 2016 ª 2016 The Authors
The EMBO Journal TDP-43 regulates trafficking of recycling endosomes Benjamin M Schwenk et al
2360
Published online: September 12, 2016 
B). Moreover, knockdown of TDP-43 in older neurons, when mature
dendritic spines are already established (DIV14+5), led to a similar
withering of the dendritic tree and significant spine loss
(Appendix Fig S4C–F). The remaining dendritic spines were signifi-
cantly thinner, indicative of reduced synaptic strength (Appendix
Fig S4G and H).
While treating control neurons with the ErbB4 ligand NRG1 for
two days enhanced the dendrite growth, NRG1 failed to promote
dendrite growth in TDP-43-knockdown neurons (Fig 9E and F),
suggesting that NRG1 signaling via ErbB4 is impaired. These effects
were fully mimicked by VPS4B overexpression (Fig EV5C and D). In
contrast, expression of ErbB4 in TDP-43-knockdown neurons led to
the complete rescue of the dendritic complexity although ErbB4
expression in the control cells only slightly enhanced branching
(Fig 9G and H). Similarly, ErbB4 expression was able to restore
dendrite branching in VPS4B-transfected neurons (Fig EV5E and F).
Thus, dendrite loss in TDP-43-knockdown neurons is at least
partially due to the impaired recycling of ErbB4 to the plasma
membrane caused by VPS4B upregulation.
Discussion
Loss of TDP-43 function is thought to be a major driver of neurode-
generation in FTLD and ALS patients with cytoplasmic TDP-43
aggregation, although the molecular mechanisms are poorly
understood. Our data establish TDP-43 as an important regulator of
recycling endosome dynamics by transcriptionally repressing the
CHMP2B-interacting protein VPS4B. Impaired trafficking of recy-
cling endosomes upon TDP-43 knockdown inhibits the cell surface
expression of ErbB4 and hence prevents the stimulation of dendrite
growth by its ligand NRG1. Thus, we directly link TDP-43 loss of
function toxicity to two genes with rare ALS/FTLD-causing
mutations, CHMP2B and ErbB4. This suggests a common pathway
leading to neurodegeneration by blocking trophic signaling through
the impaired dynamics of recycling endosomes.
Nuclear TDP-43 specifically controls dendritic trafficking of
recycling endosomes
We show that TDP-43 loss of function impairs the trafficking of
GFP-RAB11-positive recycling endosomes in the dendrites without
affecting the RAB4- and RAB5-positive endosome pools or mito-
chondria using live imaging in neurons. Impaired recycling of
fluorescently labeled transferrin despite the normal initial internal-
ization in TDP-43-knockdown neurons largely excludes confounding
effects of ectopic GFP-RAB11 expression on endosome dynamics.
Importantly, TDP-43 knockdown in iPSC-derived human neurons
also impaired recycling endosome motility, further strengthening
the relevance of this pathway for human pathophysiology. We
discovered that altered endosomal dynamics upon TDP-43 knock-
down is due to upregulation of VPS4B, an ESCRT-III disassembly
factor. TDP-43 knockdown resulted in a significant dendrite loss
that was phenocopied by the expression of VPS4B or dominant-
negative RAB11, suggesting that endosome recycling is critical for
dendrite development. We also observed a pronounced loss of
dendritic spines in TDP-43-knockdown cells, which might be
explained by the loss of synaptic receptors. Interestingly, acute
chemical inactivation of RAB11 in neurons inhibits the surface
delivery of AMPA receptors (Esteves da Silva et al, 2015).
Moreover, we noticed slightly increased motility of lysosomes,
which might relate to the autophagosome–lysosome fusion prob-
lems observed in TDP-43-knockdown cell lines recently (Xia et al,
2015). Chronic dysfunction of the cellular degradation system is
thought to promote TDP-43 aggregation (Filimonenko et al, 2007;
Tashiro et al, 2012), but further lysosomal dysfunction due to
nuclear clearance of TDP-43 might fuel a vicious cycle.
TDP-43 regulates the ESCRT factor VPS4B
To uncover the molecular mechanism of recycling endosome stal-
ling, we analyzed the whole proteome of TDP-43-knockdown
neurons using label-free quantitative proteomics. Among the dif-
ferentially expressed proteins, we focused on VPS4B, because it
had been linked to endosomal dynamics previously (Stuchell-
Brereton et al, 2007; Du et al, 2013). VPS4B mRNA and protein
levels are threefold upregulated in TDP-43-knockdown neurons
from rats and humans. Enhanced VPS4B promoter activity upon
TDP-43 knockdown suggests the transcriptional regulation of
VPS4B by TDP-43. Chromatin immunoprecipitation shows that
TDP-43 directly binds to a GT-rich region in the VPS4B promoter
region in rat primary neurons and human brain, as shown before
for TAR-DNA motif of HIV1 (Ou et al, 1995). Overexpression of
VPS4B in neurons inhibits recycling endosome transport similar
◀ Figure 7. TDP-43 knockdown reduces surface expression and the activity of ErbB4 and FGFR1.A Primary hippocampal neurons (DIV6+4) were transduced with shRNA targeting TDP-43 (shTDP) or control (shCtrl) and surface expression levels of glycoproteins
were analyzed by metabolic labeling followed by surface biotinylation and subsequent streptavidin purification. Volcano plot depicts proteins that are significantly
(P < 0.01, t-test, Benjamini–Hochberg, FDR: 0.05) decreased or increased on the cell surface in three independent experiments with two technical replicates. For full
dataset, see Table EV2.
B–E Primary cortical neurons (DIV6+5) were transduced with shCtrl or shTDP. Neurons were treated with the ErbB4 ligand NRG1 (10 nM) or FGFR1 ligand FGF1 (10 ng/
ml) for 10 min right before cell lysis. Immunoblots with the indicated antibodies (B, D). Quantification of total and phospho-ERBB4 (Y1056) and total and phospho-
FGFR1 (Y654) using densitometry of three to seven biological replicates (C, E).
F Primary hippocampal neurons (DIV6+4) were transduced with shTDP or shCtrl. Gene expression was analyzed by quantitative RT-PCR normalized to the
housekeeping genes YWHAZ and GAPDH (n = 3)
G Hippocampal neurons were transfected with ErbB4 containing a luminal HA-tag (HA/T-ErbB4) and shCtrl or shTDP (DIV9+3). Surface HA/T-ErbB4 was stained in
living cells and intracellular HA/T-ErbB4 was stained after fixation and permeabilization with HA antibodies. Scale bar represents 50 lm.
H Quantification of HA/T-ErbB4 surface levels. At least 10 images per condition per experiment were analyzed in three independent experiments
Data information: Mean  s.e.m., unpaired, two-tailed t-test: *P < 0.05, **P < 0.01.
Source data are available online for this figure.
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to TDP-43 knockdown. Importantly, preventing VPS4B upregula-
tion using shRNA completely rescues recycling endosome motility
in TDP-43-knockdown neurons, strongly suggesting that VPS4B
upregulation is the major cause of the trafficking deficits upon
TDP-43 knockdown.
VPS4 controls normal endosomal trafficking and sorting and is
required for disassembly of the ESCRT-III complex (Yoshimori
et al, 2000; Jouvenet, 2012). Promoting ESCRT assembly by ALIX
overexpression also largely restored the trafficking deficits in
TDP-43-knockdown cells (Adell & Teis, 2011). VPS4B directly
interacts with the ALS-associated CHMP2B, another crucial part
of the ESCRT-III complex, and this interaction is blocked by ALS/
FTLD-causing mutations in CHMP2B (Skibinski et al, 2005;
Stuchell-Brereton et al, 2007; Han et al, 2012). Several other VPS
family members have been genetically linked to neurodegenera-
tive disorders, for example, VPS35 to Parkinson’s disease and the
VPS10 proteins SORL1 and SORCS1 to Alzheimer’s disease (Lane
et al, 2012). Thus, linking TDP-43 loss of function to VPS4B,
thus the ESCRT complex, and impaired recycling endosome
motility further highlights the role of vesicle trafficking in
neurodegeneration.
TDP-43 loss of function impairs cell surface expression of key
receptors for growth and guidance factors
The balance of endocytosis and recycling regulates the homeo-
stasis of adhesion molecules and receptors for neurotransmitters,
growth factors, and guidance cues (Goh & Sorkin, 2013). To iden-
tify the proteins most affected by impaired recycling endosome
dynamics in neurons, we analyzed the changes in the surface
proteome upon TDP-43 knockdown using proteomics (Kuhn et al,
2012). Reduced surface expression is likely due to the impaired
recycling, because TDP-43 knockdown has no apparent effect on
transferrin endocytosis or on trafficking of RAB5-positive early
endosomes. We found a highly significant reduction of 43
proteins on the surface, many of them known cargoes of recy-
cling endosomes, while only two surface proteins were signifi-
cantly upregulated. Among the proteins with reduced surface
expression upon TDP-43 knockdown, only two of ten tested
mRNAs were significantly downregulated, suggesting that the traf-
ficking effects are dominant.
More than half of the proteins with reduced surface expression
are involved in dendrite growth (e.g., ErbB4, FGFR1, EphB2) or
axonal guidance (e.g., Robo1, Unc5c/d, EphB2, TrkB). In flies,
TDP-43 knockout impairs the dendrite growth by a cell autonomous
mechanism (Lu et al, 2009). We found that TDP-43 knockdown in
rat primary neurons also leads to the loss of dendrites and dendritic
spines, thus potentially compromising synaptic transmission. We
focused on the receptor tyrosine kinase ErbB4, one of the most
downregulated proteins on the cell surface, because it had previ-
ously been linked to ALS through rare pathogenic mutations in its
kinase domain that inhibit response to its ligand NRG1 (Takahashi
et al, 2013). Although ErbB4 is predominantly expressed in
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Figure 8. TDP-43 knockdown delays the surface delivery of ErbB4.
A, B Primary hippocampal neurons (DIV6+3) were transfected with shCtrl or shTDP and ErbB4 containing an N-terminal HA epitope tag and followed by thrombin
cleavage site (HA/T-ErbB4). Surface HA/T-ErbB4 was stained in living cells and intracellular HA/T-ErbB4 was stained after fixation and permeabilization with two
different HA antibodies. After removing the HA signal of surface ErbB4 (0 min) using thrombin cleavage (5 min, 1 U/ml), membrane insertion of HA/T-ErbB4 was
measured at the indicated time points. The steady state (StSt) before thrombin cleavage is also depicted. At least 10 images per condition per experiment were
analyzed in three independent experiments. Scale bar represents 50 lm. Mean  s.e.m., unpaired, two-tailed t-test: *P < 0.05, **P < 0.01.
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Figure 9. TDP-43 knockdown blunts dendritic complexity and response to NRG1.
Primary hippocampal neurons (DIV6+4) were cotransfected with shTDP, VPS4B, or appropriate controls and GFP to visualize neuron morphology. Dendritic morphology from
at least 23 neurons per condition per experiment was quantified by Sholl analysis and statistically evaluated using two-way ANOVA with Bonferroni’s (B, D) or Tukey’s (F, H)
post-test. Scale bar represents 100 lm. Mean  s.e.m..
A, B TDP-43 knockdown (DIV6+5) significantly reduces dendrite branching compared to control: at 25, 37.5, and 87.5 lm radius P < 0.05, at 50 lm P < 0.01, and from
62.5 to 75 lm P < 0.001.
C, D VPS4B transfection (DIV6+4) significantly reduces dendrite complexity: at 25 lm radius P < 0.05, from 37.5 to 75 lm P < 0.001, and from 87.5 to 100 lm P < 0.01.
E, F Two days after shRNA transfection, the neurons were treated with 1 nM NRG1-beta 1 (NRG1) or vehicle and analyzed at DIV6+5. shCtrl vs. shTDP: at 25 and
87.5 lm radius P < 0.05, from 37.5 to 75 lm P < 0.001. shCtrl vs. shCtrl + NRG1: from 37.5 to 62.5 lm P < 0.05. shTDP vs. shTDP+NRG1: no significant difference.
G, H Transfection of the indicated combinations of shCtrl, shTDP, ErbB4, or vector control (DIV6+5). shCtrl + Ctrl vs. shTDP + Ctrl: from 25 to 75 lm radius P < 0.001, at
87 and 112.5 lm P < 0.01, and at 100 lm P < 0.05. shTDP + Ctrl vs. shTDP + ErbB4: from 25 to 100 lm radius P < 0.001, at 112.5 lm P < 0.01. shCtrl + Ctrl vs.
shTDP + ErbB4: no significant differences.
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expression in excitatory neurons is still crucial to regulate
dendritic spine morphology and synaptic plasticity (Li et al, 2007;
Cooper & Koleske, 2014). We observed an enhanced dendritic
branching upon NRG1 treatment in excitatory control neurons,
similar to previous findings (Gerecke et al, 2004; Krivosheya et al,
2008; Allison et al, 2011). In contrast, the stunted dendrite
growth in TDP-43-knockdown cells could not be stimulated by
NRG1 treatment, indicating that an impaired trafficking of
recycling endosomes blocks the NRG1/ErbB4 signaling axis.
Importantly, increasing ErbB4 levels in TDP-43-knockdown
neurons restored dendritic arborization to control conditions,
suggesting that reduced ErbB4 surface expression is a major cause
for the dendrite withering in our system. We could reproduce all
ErbB4-related findings also in VPS4B-overexpressing neurons,
strongly suggesting that VPS4B upregulation and its effect on
endosome trafficking directly inhibit receptor recycling upon
TDP-43 knockdown.
TDP-43 knockdown reduced surface expression of many other
receptors for growth and guidance cues and thus presumably has
more widespread effects on trophic signaling. Depending on cell
type and age, other plasma membrane proteins undergoing recy-
cling might be affected. For example, the reduced levels of CADM3
found in the CSF of ALS patients (Collins et al, 2015) could be
explained by the reduced cell surface expression (Fig 7A) and
subsequent shedding upon the loss of nuclear TDP-43. Additionally,
we found reduced mRNA expression and surface expression of the
hepatocyte growth factor (HGF) receptor c-Met. Interestingly,
muscle-derived HGF promotes the axon outgrowth and survival of
motoneurons during development via c-Met (Ebens et al, 1996) and
HGF/c-Met expression declines with disease progression in ALS
patients (Kato et al, 2003). Many of these signaling pathways have
been most extensively studied during development, but remain
essential in adulthood and might be even more critical upon injury
or neuronal damage. For example, FGF signaling is crucial for
motoneuron protection and survival after spinal cord injury (Teng
et al, 1999). Thus, the impaired activity of ErbB4, FGFR1, c-Met,
and other receptor tyrosine kinases may deprive neurons with
TDP-43 mislocalization and aggregation from crucial trophic support
leading to progressive neuron loss. Interestingly, the removal of
established TDP-43 aggregates and the subsequent restoration of
nuclear TDP-43 expression lead to functional reinnervation in an
inducible mouse model, further supporting a role of TDP-43 in
trophic signaling (Walker et al, 2015).
Clinical implications
Three lines of evidence support that an impaired endosomal recy-
cling occurs in ALS and FTLD patients. First, we observed the
reduced recycling endosome motility and VPS4B upregulation upon
TDP-43 knockdown in human iPSC-derived neurons. Second,
region-specific elevation of VPS4B in sections of ALS-TDP and
FTLD/ALS-TDP patients suggests that TDP-43 loss of function in
patients with TDP-43 aggregation invokes a similar mechanism as in
cultured neurons. Third, ALS patients have reduced transferrin
levels in serum and CSF (Brettschneider et al, 2008; Nadjar et al,
2012), a result we confirmed in our cohort of sporadic ALS patient
for the CSF-specific b2-transferrin. This finding can now be
explained by the impaired transferrin transport and recycling caused
by TDP-43 loss of function. Moreover, our findings could also
be relevant for Alzheimer’s disease, as TDP-43 aggregation and
nuclear clearance are found in up to 50% of cases (Davidson et al,
2011).
Our work establishes a connection between TDP-43, impaired
vesicle trafficking, and dendrite growth by controlling cell surface
expression of receptors crucial for neurite outgrowth and neuronal
survival. Impaired recycling of trophic receptors to the cell surface
due to nuclear clearance of TDP-43 and VPS4B upregulation in




Myc-tagged human TDP-43 wild type and the DNLS (97AAA)
mutant cDNA were expressed from pcDNA6 vector driven by CMV
promoter. Myc-tagged rat VPS4B, human HA/T-ErbB4 (HA-tag
followed by a thrombin cleavage site (LVPRGS) were inserted
directly after the signal sequence, cloned from Addgene plasmid
#29527, Yardena Samuels (Prickett et al, 2009)), and human ALIX
(subcloned from Addgene plasmid #21504, James Hurley (Lee et al,
2008)) cDNA was expressed from a lentivirus plasmid driven by
ubiquitin promoter (Orozco et al, 2012). shRNAs were cloned into
pSUPER (target sequences: rat TDP-43 #1 gtagatgtcttcattcccaaa, rat
TDP-43 #2 gctgatgggctgcgaacat, human TDP-43: gaaacacaagtgaaag
taa, rat VPS4B: ggtgcagatcagcgtgaca and luciferase control cgtacgcg
gaatacttcga). For lentiviral knockdown, the H1 promoter shRNA
expression cassette was subcloned into a lentiviral vector coexpress-
ing mCherry from human ubiquitin C promoter (Orozco et al,
2012). Human RAB4 (Addgene #54943, M. Davidson unpublished),
RAB5 (Lang et al, 2012), RAB7 and RAB11a wild type and S25N
(Addgene #12605, 12674, 12678, Richard Pagano (Choudhury et al,
2002)) were expressed from pEGFP-C1 vector. Mito-GFP contains
the mitochondrial targeting sequence of COX8. For the luciferase
reporter construct, genomic sequence 1 kb upstream of the
predicted TSS (http://www.cbs.dtu.dk/services/Promoter/) until
the start codon of rat VPS4B was cloned in upstream of Renilla
luciferase in the psiCheck2 vector (primers gatggatccctcccatac
actacaaggggaagctc and gatgctagctggtggagatccaaagggtccccta). All
constructs were verified by sequencing.
Lentivirus was produced by cotransfecting psPAX2, pVSV-G, and
the respective overexpression or knockdown constructs in
HEK293FT as described before (Schwenk et al, 2014). After harvest-
ing the supernatant, virus particles were concentrated by ultra-
centrifugation and resuspended in PBS.
Antibodies and reagents
Antibodies against TDP-43 (Sigma-Aldrich Cat# SAB4200006, Cosmo
Bio Co Cat# CAC-TIP-TD-P09), GFP (UC Davis/NIH NeuroMab Facil-
ity Cat# 73-132), b-actin (Sigma-Aldrich Cat# A5316), calnexin (Enzo
Life Sciences Cat# ADI-SPA-860-F), VPS4B (Sigma-Aldrich Cat# PA5-
30316 for IHC and Proteintech Group Cat# 17673-1-AP for
immunoblotting and immunofluorescence), ErbB4 (Santa Cruz
Biotechnology Cat# sc-283), phosphor-ErbB4-Y1056 (Santa Cruz
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Biotechnology Cat# sc-33040), FGFR1 (Novus Cat# NB600-1287),
phosphor-FGFR1-Y654 (Abcam Cat# ab59194), myc-tag (Santa Cruz
Biotechnology Cat# sc-40), HA-tag (Sigma-Aldrich Cat# H9658 and
Roche Cat# 3F10), anti-mouse and rabbit HRP-coupled secondary
antibodies and anti-mouse and rabbit Alexa-coupled secondary anti-
bodies (Life Technologies) are commercially available. TO-PRO 3
and transferrin-Alexa 555 were purchased from Life Technologies,
and DAPI and EZ-Link sulfo-NHS-LC biotin from Sigma-Aldrich.
b2-Transferrin protein levels from undiluted CSF samples derived
from sporadic ALS patients and controls were quantified using
a commercially available ELISA kit (www.mybiosource.com,
MBS923983) following the manufacturer’s instructions. Recombi-
nant NRG1 and FGF1 were purchased from R&D Systems.
Neuron cell culture and imaging
Hippocampal neurons were prepared from embryonic day 18 CD
rats (Charles River), cultivated in Neurobasal media (with 2% B27,
0.25% glutamine, 0.125% glutamate), and transduced with lenti-
virus or transfected with Lipofectamine 2000 as described before
(Schwenk et al, 2014). Immunoblotting and immunostaining were
performed as described previously (Schwenk et al, 2014). Images
were taken on Zeiss LSM 510 or 710 confocal laser scanning micro-
scopes using 40× (NA = 1.3) oil immersion objectives with 1 Airy
unit pinhole. Dendritic arborization was quantified manually by
Sholl analysis as described previously (Schwenk et al, 2014). In
each experiment, at least 30 neurons per condition were imaged and
quantified. Figures show the representative data from one of at least
three independent replicates with similar results. All image acquisi-
tion and quantification for morphological analyses were done blind
to the experimental conditions.
iPSC-derived human neurons were generated as described before
(Koch et al, 2009) and frozen in liquid nitrogen for long-term stor-
age. After thawing, neurons were plated on PDL-coated glass-
bottom dishes in HN media (DMEM/F12 and Neurobasal 1:1, 0.5%
N2, 1% B27, 0.1 % glucose, 2 lg/ml insulin, 10 ng/ml GDNF,
10 ng/ml BDNF, 10 lM Y-27632). Every two days half of the media
were exchanged. Neurons were transduced with lentivirus seven
days after thawing and imaged three days later.
Astrocyte feeder cells were prepared from embryonic day 18 CD
rats (Charles River) as described previously (Kaech & Banker,
2006), plated onto glass coverslips, and maintained in MEM supple-
mented with 0.6% glucose and 5% FBS till they reached 50–60%
confluency.
Live cell imaging
For vesicular motility analysis, images for time-lapse movies were
taken on a Zeiss Cell observer SD spinning-disk microscope with an
air-cooled Evolve 512 EMCCD camera at 5 Hz for 60 s (RAB11),
2 Hz for 150 s (RAB4, RAB5, mitochondria), or 1 Hz for 300 s
(RAB7) with an 63× oil immersion objective (NA = 1.4). During
image acquisition, neurons were kept in a climate chamber (37°C,
5% CO2). Unless noted otherwise, kymographs of vesicular move-
ment from at least four dendrite segments per cell and at least six
neurons per condition and experiment were generated and manually
analyzed using ImageJ software (Multiple Kymograph plugin by
J. Rietdorf and A. Seitz).
Transferrin recycling assay
The protocol for transferrin recycling assay was adapted (Moreau
et al, 2012). Neurons were transduced with the lentiviruses coex-
pressing shRNA and RFP. On day five, cells were starved in culture
media without B27 (30 min at 37°C and 5% CO2) prior to incuba-
tion with 50 lg/ml transferrin-Alexa-488 in complete culture media
for 20 min at 4°C. Subsequently, neurons were put back at 37°C and
5% CO2 for 20 min to allow transferrin internalization (pulse).
Afterward, the cells were washed three times, put back in complete
culture media (containing unlabeled transferrin as part of B27) for
0, 20, or 60 min (chase), and fixed (4% PFA, 4% sucrose) after
another wash with PBS. Transferrin-Alexa-488 was quantified from
confocal images by relating transferrin fluorescence signal to the cell
area, visualized by RFP expression (not shown in Fig 2), and
normalized to control transduced cells.
VPS4B promoter assay
A modified psiCHECK2-expressing Renilla luciferase from a 1-kb
VPS4B promoter fragment and firefly luciferase from the TK
promoter was cotransfected with control or TDP-43 constructs at a
40:60 ratio into HEK283FT cells using Lipofectamine 2000 (Life
Technologies). On day 3, luciferase activity was quantified using
Dual-Glo Luciferase Assay (Promega). Relative promoter activity
was determined by normalizing the ratio of Renilla luciferase and
firefly luciferase to the control vector and the effect on the original
psiCHECK2 vector. All experiments were performed in 96-well
plates with six replicates for each condition.
Chromatin immunoprecipitation (ChIP)
ChIP experiments in cortical neurons, HEK293 cells, and brain tissue
were performed using the MAGnify Chromatin Immunoprecipitation
System (Thermo Fisher Scientific) according to the manufacturer’s
instructions. Briefly, chromatin from 300,000 cells or 20 mg tissue
per ChIP reaction was crosslinked by 1 % formaldehyde and
sheared with a Branson WD200 sonifier (30% amplitude, 60% duty
cycle, 4× 30-s impulse, 60-s recovery) to an approximate size of
300–500 bp. Following cell lysis, protein was immunoprecipitated
using either rabbit polyclonal TDP-43 (Cosmo Bio, CAC-TIP-TD-
P09) or rabbit control antibody. After five washing steps, the cross-
link was reversed in immunoprecipitates and input samples
followed by proteinase K digestion. Afterward, DNA was isolated
and PCRs from input, control- and TDP-43-IP were performed
amplifying ~200-bp amplicons in the promoter region of VPS4B.
We detected binding with the following amplicons in rats
(gcagagggaaacagaaatta, ctagctctattcacacacac) and humans (gctcgttc
ccgcttgttc, tggtggctgcaaaccatag).
Surface staining and thrombin cleavage assay
The protocol for receptor surface quantification and thrombin
cleavage assay was adapted from Passafaro et al (2001). In brief,
hippocampal neurons (DIV7+4) were transfected with HA/T-ErbB4
and shTDP or shCtrl and incubated for 4 days. Cells were live-
labeled with rat anti-HA antibody for 1 h at 4°C to visualize
surface HA proteins, washed with cold Neurobasal media, and
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fixed for 8 min in 4% PFA. Afterward, fixed neurons were incu-
bated with mouse anti-HA to label intracellular receptors. The
neurons were washed in 20 mM phosphate buffer containing
0.5 M NaCl (pH 7.4), incubated in Alexa-labeled secondary anti-
bodies, and mounted. For the quantification of receptor recycling
to the plasma membrane, HA/T-ErbB4-transfected hippocampal
neurons were treated for 5 min with thrombin (Sigma-Aldrich;
1 U/ml), followed by three washing steps with warm Neurobasal.
Subsequently, the cells were returned to 37°C to allow for
membrane insertion of new receptors. Neurons were labeled as
described above either without thrombin treatment, or 0, 30, or
60 min after thrombin treatment. Images were taken with a Zeiss
LSM 710 confocal microscope.
Quantification of immunofluorescence images
Images were acquired on a Zeiss LSM 710 laser scanning confocal
microscope using the same settings during the whole experiment.
Fluorescence levels were quantified with ImageJ by using the back-
ground corrected total cell fluorescence. The total corrected cellular
fluorescence (TCCF) = integrated density – (area of selected
cell × mean fluorescence of background readings), was calculated
(McCloy et al, 2014). All image acquisition and quantification were
performed blinded to the experimental conditions.
RNA preparation and quantitative PCR
RNA was isolated using RNeasy Mini Kit with the optional DNase
digest step (Qiagen) following the manufacturer’s instructions.
cDNA was generated using the TaqMan MicroRNA Reverse Tran-
scription Kit (Applied Biosystems) with random hexamer primers
following the manufacturer’s instructions. RT-qPCR was performed
on CFX384-Real-Time system using SsoFast EvaGreen (Bio-Rad)
with a two-step protocol using the following primers: rat VPS4B
(primers ccaccatggcgtccacgaacac and tggccctgatgctttgcttggc), rat
TDP-43 (agtgttgggtctcccctggaaa, acagtcacaccatcgcccatct), rat
YWAHZ (tgagcagaagacggaaggtgctg, tctgatggggtgtgtcggctgc), and rat
GAPDH (ccgcatcttcttgtgcagtgcc, agactccacgacatactcagcacc). Amplifi-
cation of a single product was confirmed by melting curve analy-
sis. Relative mRNA abundance was quantified by the DDCT
method.
Human samples
Human CSF samples were provided by the MND-NET and the
German FTLD consortium. All patient tissues were provided by the
Neurobiobank Munich, Ludwig Maximilians University (LMU) of
Munich. All samples were collected and distributed according to the
guidelines of the local ethical committee.
Immunofluorescence of paraffin sections
Immunofluorescence was performed as previously described
(Mackenzie et al, 2013). In short, paraffin sections were dewaxed in
xylene and ethanol followed by microwaving in citrate buffer (pH
6). The VPS4B and TDP-43 antibodies were incubated overnight at
4°C, and the fluorescence-labeled secondary antibody 1 h at room
temperature. Nuclei were stained with DAPI for 15 min.
Statistical analysis
Statistical analysis was performed using GraphPad Prism software.
If sample size allowed, data were tested for normal distribution with
D’Agostino–Pearson omnibus normality test. If data points were not
normally distributed, a nonparametric test was used, when applica-
ble. To compare one variable in two independent groups, the
unpaired, two-sided t-test or Mann–Whitney U-test were used; in
cases with three or more independent groups, one-way ANOVA or
Kruskal–Wallis test were used. To compare groups using two vari-
ables, two-way ANOVA was applied. If necessary, tests were
corrected for multiple comparisons using the Bonferroni or Tukey
method owing to the applied test and the number of groups. A
P-value < 0.05 was considered significant. Statistical analysis of
proteomic data is described in detail below.
Whole proteome analysis by LC-MS/MS
Cells were lysed in SDS-containing buffer and subjected to tryptic
digestion as described previously (Hornburg et al, 2014). We
separated peptides on a HPLC (EASY-nLC 1000, Thermo Fisher
Scientific, Odense, Denmark) using 50-cm columns (75-lm inner
diameter) in-house packed with 1.9-lm C18 beads (Dr. Maisch
GmbH, Ammerbuch-Entringen, Germany). Peptides were loaded
in 0.5% formic acid (buffer A) and eluted within a 245-min gradi-
ent from 5% buffer B (80% acetonitrile, 0.5% formic acid) to
60% B at 250 nl/min. The column was heated to 50°C to reduce
backpressure. Our setup employed a hybrid quadrupole Orbitrap
mass spectrometer (Michalski et al, 2011) (Orbitrap Q Exactive,
Thermo Fisher Scientific) directly coupled to the HPLC via nano-
electrospray source. The survey scan (MS1, 300 to 1,650 m/z)
was performed at a resolution of 70,000 at m/z 200 and an ion
target value of 3E6. Up to the top 10 most intense features with a
charge state higher than one not picked previously (dynamic
exclusion window 30 s) were subjected to HCD fragmentation
(AGC target 1e5, isolation window 2.2 m/z) at a normalized colli-
sion energy of 25. Data were acquired using Xcalibur software
(Thermo Scientific).
Whole proteome raw data analysis and statistical analysis
We processed the raw data with MaxQuant (Cox & Mann, 2008)
(v. 1.4.1.6) and used the integrated search engine Andromeda
(Cox et al, 2011) to search MS/MS spectra against the rat
UniProtKB Fasta database (34,562 forward entries; version from
July 2015). The enzyme specificity was set to trypsin while allow-
ing up to two miscleavages and cleavage N-terminal to proline.
We set the minimum length of peptides to be considered for iden-
tification to seven amino acids assuming carbamidomethylation of
cysteine as fixed and methionine oxidation (M) as well as acetyla-
tion of N-termini as variable modifications. A false discovery rate
(FDR) cutoff of 1% was applied on both the peptide and protein
level.
We performed nonlinear retention time alignment of all
measured samples in MaxQuant, which allows us to transfer
peptide identifications in the absence of sequencing (MS1 only),
within a narrow retention time window of 1 min (“match
between runs”). We employed a library of 20 cortical rat neuron
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proteomes as a library for matching. Protein intensities were
normalized with MaxQuant (MaxLFQ; Cox et al, 2014). We strin-
gently filtered our data requiring at least two peptide ratios for
protein quantification. In addition, common contaminants
(n = 247, included in MaxQuant software packages) as well as
proteins only identified with side modifications were strictly
excluded from the analysis. Furthermore, we removed any protein
group with less than two-third valid values for either control or
knockdown from the analysis. Remaining missing values were
imputed with a normal distribution (based on whole data distribu-
tion, width = 0.3, downshift = 1.8).
For statistical analysis, we employed Perseus, which is part of
the MaxQuant environment. To emphasize the strength of biological
differences, we employed a S0 correction of 0.1 in the statistical
analysis (Student’s t-test) (Tusher et al, 2001). The biological dif-
ference between TDP-43 knockdown and control was mild and we
had to choose a slightly less stringent multiple testing correction
(permutation-based FDR of 0.1 instead of 0.05) to determine the
most significant outliers for biological validation. To visualize global
trends in the dataset, we performed a 1D annotation enrichment
(Benjamini–Hochberg FDR cutoff of 0.05) based on the differences
in means. Significantly enriched annotations (KEGG name, GOMF
name, keyword, GOCC slim name) are depicted in table (1D annota-
tion enrichment). For biological follow-ups, we focused on proteins
with highest fold change.
Labeling of glycoproteins at the cell surface and mass
spectrometric analysis
The protocol was adapted from Kuhn et al (2012); 4.5 million
neurons in a 10-cm dish labeled for 48 h with 200 nM ManNAz
was washed twice with cold PBS. Afterward, 100 nM DBCO-
PEG12-biotin (Click Chemistry Tools) diluted in 2 ml PBS was
evenly distributed on the neurons and incubated at 4°C for 2 h.
Neurons were washed twice with PBS and then lysed in 5 ml
buffer (150 mM NaCl, 50 mM Tris, 2 mM EDTA, 1 % NP-40) per
dish. After centrifugation at 4,000 g, equal protein amounts of the
clarified lysate were loaded on a PolyPrep column with a strepta-
vidin bead bed (300 ll slurry). After binding of proteins, strepta-
vidin beads were washed three times with 10 ml PBS
supplemented with 1% SDS. To elute the biotinylated glycopro-
teins, streptavidin beads were boiled with urea sample buffer
containing 3 mM biotin.
Samples were analyzed twice using an Easy-NLC 1000 nano-
flow HPLC system II (Proxeon) connected to an LTQ-Velos
Orbitrap Pro (Thermo Fisher Scientific). Peptides were sepa-
rated by reverse-phase chromatography using in-house-made
30-cm columns (New Objective, FS360-75-8-N-S-C30) packed with
C18-AQ 2.4-lm resin (Dr Maisch GmbH, Part No. r124.aq). A
90-min gradient (5–40%) at a flow rate of 200 nl/min was used.
The measurement method consisted of an initial FTMS scan
recorded in profile mode with 30,000 m/z resolution, a mass
range from 300 to 2,000 m/z, and a target value of 1,000,000.
Subsequently, collision-induced dissociation (CID) fragmentation
was performed for the 15 most intense ions with an isolation
width of 2 Da in the ion trap. A target value of 10,000, enabled
charge state screening, a monoisotopic precursor selection, 35%
normalized collision energy, an activation time of 10 ms, wide
band activation, and a dynamic exclusion list with 30-s exclu-
sion time were applied.
Data from three independent experiments with two technical
replicates were analyzed with MaxQuant suite (version 1.5.3.12)
in combination with the Andromeda search algorithm as above.
First search, mass recalibration, and main search of tryptic
peptides were performed using a rat Uniprot database downloaded
on the 21 August 2012. Two missed cleavages were allowed.
Peptide as well as protein false discovery rate was set to 1%.
Mass accuracy was set to 20 ppm for the first search and 5 ppm
for the main search. Quantification was performed between the
respective control and TDP-43-knockdown condition on the basis
of unique and razor peptides. Missing values were imputed in
Perseus 1.5.16 following a standard distribution. P-values were
calculated from log2-transformed LFQ ratios using a heteroscedas-
tic, two-sided Student’s t-test. Proteins with a P-value of P ≤ 0.05
were considered as hits. To correct for multiple hypothesis testing,
the Benjamini–Hochberg post-test was applied with an adjusted
false discovery rate of 0.05.
Data availability
The mass spectrometry data have been deposited to the ProteomeX-
change Consortium via the PRIDE (Vizcaino et al, 2016) partner
repository [http://www.ebi.ac.uk/pride/] with the dataset identifier
PXD004756 (whole proteome) and PXD004744 (cell surface
proteome).
Expanded View for this article is available online.
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